Table 4.
Postoperative outcomes
| Total | COVID-19 (+) | COVID-19 (−) | p value | |
|---|---|---|---|---|
| Patients | 701 | 39 | 662 | – |
| 30-day mortality; n (%) | ||||
| Yes | 14 (2%) | 5 (12.8%) | 9 (1.4%) | < 0.001 |
| No | 687 (98%) | 34 (87.2%) | 653 (98.6%) | |
| Respiratory mortality; n (%) | ||||
| Yes | 6 (42.9%) | 5 (100%) | 1 (11.1%) | 0.006 |
| No | 8 (57.1%) | 0 (0%) | 8 (88.9%) | |
| Postoperative complications; n (%) | ||||
| Without complications | 601 (85.7%) | 21 (53.9%) | 580 (87.6%) | < 0.001 |
| Clavien-Dindo I-II | 45 (6.4%) | 8 (20.5%) | 37 (5.6%) | |
| Clavien-Dindo ≥ III | 55 (7.9%) | 10 (25.6%) | 45 (6.8%) | |
| Respiratory morbidity; n (%) | ||||
| Yes | 21 (3%) | 12 (30.8%) | 9 (1.4%) | < 0.001 |
| No | 680 (97%) | 27 (69.2%) | 653 (98.6%) | |
| IMV requirement | ||||
| Yes | 8 (38.1%) | 6 (50%) | 2 (22.2%) | 0.401 |
| No | 13 (61.9%) | 6 (50%) | 7 (77.8%) | |
| Readmission | ||||
| Yes | 34 (4.9%) | 8 (20.5%) | 26 (3.9%) | < 0.001 |
| No | 667 (95.1%) | 31 (79.5%) | 636 (96.1%) | |
| Readmission by cause | ||||
| Medical | 16 (47.1%) | 5 (62.5%) | 11 (42.3%) | 0.551 |
| Surgical | 18 (52.9%) | 3 (37.5%) | 15 (57.7%) | |
| Reoperation | ||||
| Yes | 31 (4.4%) | 2 (5.1%) | 29 (4.4%) | 0.825 |
| No | 670 (95.6%) | 37 (94.9%) | 633 (95.6%) | |
IMV invasive mechanical ventilation